Form 4: Nutex Health Director Granted 823 RSUs

Nutex Health Inc. Director Frank E. Jaumot received a grant of 823 Restricted Stock Units, vesting 100% on April 23, 2027.

Summary

• Frank E. Jaumot, a Director of Nutex Health Inc. (NUTX), was granted 823 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.
• The RSUs were granted on April 23, 2026, and are scheduled to vest 100% on April 23, 2027.
• If the reporting person leaves service with the Company without cause during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service.
• Following this transaction, Frank E. Jaumot beneficially owns 1,426 derivative securities (RSUs).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard director compensation practices and aligning insider interests with long-term company performance, without significant immediate impact on company fundamentals.

Positives

• The grant of 823 RSUs aligns the director's interests with long-term shareholder value.
• The vesting schedule encourages continued service and commitment from the director.

Negatives

• Potential for minor future dilution for existing shareholders upon vesting and conversion of RSUs into common stock.

Risks

• Future stock price performance could impact the ultimate value of the RSUs for the director.
• Pro-rata vesting if the director leaves service without cause during the vesting period could reduce the intended long-term incentive.

Future Outlook

The 823 RSUs granted to Director Frank E. Jaumot are scheduled to vest 100% on April 23, 2027, contingent on continued service or pro-rata vesting under specific conditions.

Industry Context

StockSavvy.ai notes that RSU grants are a common form of equity compensation for directors and executives, designed to align their interests with long-term company performance and shareholder value. This grant is consistent with typical corporate governance practices for incentivizing leadership.

Stakeholder Impact

• Shareholders: Potential for minor future dilution upon vesting of RSUs, but also improved alignment of director's interests with long-term stock performance.
• Director (Frank E. Jaumot): Receives a significant equity incentive, increasing personal stake in the company's success.

Next Steps

• Vesting of the 823 RSUs on April 23, 2027, subject to the terms of the grant.
• Conversion of vested RSUs into common stock of Nutex Health Inc.

Key Dates

Keywords

Nutex Health, NUTX, Restricted Stock Units, RSU, Director Compensation, Insider Grant, Form 4, Equity Incentive